Technical Analysis for MIRA - MIRA Pharmaceuticals, Inc.
| Grade | Last Price | % Change | Price Change |
|---|---|---|---|
| F | 0.66 | -3.61% | -0.02 |
MIRA closed down 3.61 percent on Friday, May 17, 2024, on 11 percent of normal volume. The bears made the stock sink to a new 52-week low. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- so don't be surprised if it goes sideways or bounces.
| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Weak or Absent | Down | Down | Down |
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| New 52 Week Closing Low | Bearish | 0.00% | |
| Lower Bollinger Band Walk | Weakness | 0.00% | |
| New 52 Week Low | Weakness | 0.00% | |
| Wide Bands | Range Expansion | 0.00% | |
| Gapped Up | Strength | 0.00% | |
| Down 3 Days in a Row | Weakness | 0.00% | |
| Lower Bollinger Band Touch | Weakness | 0.00% | |
| Oversold Stochastic | Weakness | 0.00% | |
| MACD Bearish Signal Line Cross | Bearish | -3.61% | |
| New 52 Week Closing Low | Bearish | -3.61% |
| Alert | Time |
|---|---|
| Gap Up Closed | 1 day ago |
| Gap Up Partially Closed | 1 day ago |
| 60 Minute Opening Range Breakdown | 1 day ago |
| Down 5% | 1 day ago |
| Down 3% | 1 day ago |
Free Daily (Stock) Chart Reading
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 02/28/2024
MIRA Pharmaceuticals, Inc. operates as a clinical development stage biopharmaceutical company. The company focuses on the development and commercialization of a new molecular synthetic tetrahydrocannabinol (THC) analog under investigation for the treatment of adult patients with anxiety and cognitive decline typically associated with early-stage dementia. It is developing MIRA1a, a synthetic cannabinoid analog for treating anxiety and chronic pain by targeting the cannabinoid type 1 and type 2 receptors. The company was formerly known as MIRA1a Therapeutics, Inc. MIRA Pharmaceuticals, Inc. was incorporated in 2020 and is headquartered in Baltimore, Maryland.
Sector: Healthcare
Industry: Drug Manufacturers - General
Keywords: Cannabis Euphoriants Chronic Pain Entheogens Cannabinoid Antiemetics Ajulemic Acid Appetite Stimulants
Classification
Sector: Healthcare
Industry: Drug Manufacturers - General
Keywords: Cannabis Euphoriants Chronic Pain Entheogens Cannabinoid Antiemetics Ajulemic Acid Appetite Stimulants
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 7.9799 |
| 52 Week Low | 0.6309 |
| Average Volume | 708,031 |
| 200-Day Moving Average | 2.45 |
| 50-Day Moving Average | 0.97 |
| 20-Day Moving Average | 0.78 |
| 10-Day Moving Average | 0.72 |
| Average True Range | 0.07 |
| RSI (14) | 27.54 |
| ADX | 24.56 |
| +DI | 9.29 |
| -DI | 22.01 |
| Chandelier Exit (Long, 3 ATRs) | 0.69 |
| Chandelier Exit (Short, 3 ATRs) | 0.85 |
| Upper Bollinger Bands | 0.93 |
| Lower Bollinger Band | 0.64 |
| Percent B (%b) | 0.05 |
| BandWidth | 36.43 |
| MACD Line | -0.07 |
| MACD Signal Line | -0.07 |
| MACD Histogram | -0.0023 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 0.78 | ||||
| Resistance 3 (R3) | 0.79 | 0.75 | 0.76 | ||
| Resistance 2 (R2) | 0.75 | 0.72 | 0.75 | 0.75 | |
| Resistance 1 (R1) | 0.70 | 0.70 | 0.68 | 0.70 | 0.75 |
| Pivot Point | 0.67 | 0.67 | 0.66 | 0.66 | 0.67 |
| Support 1 (S1) | 0.62 | 0.63 | 0.60 | 0.61 | 0.56 |
| Support 2 (S2) | 0.58 | 0.62 | 0.58 | 0.56 | |
| Support 3 (S3) | 0.54 | 0.58 | 0.55 | ||
| Support 4 (S4) | 0.53 |
